EUCTR2014-005369-64-ES
Active, not recruiting
Not Applicable
Improve the myocardial reperfusion in ST elevation myocardial infarction: a randomized study between standard percutaneous coronary intervention with thrombectomy and pharmacological approach guided by the angiographic evidence of thrombus - iBEAST
ConditionsST elevation myocardial infarctionMedDRA version: 17.1Level: LLTClassification code 10064345Term: ST segment elevation myocardial infarctionSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
DrugsMetalyse
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ST elevation myocardial infarction
- Sponsor
- Consorci MAr Parc de Salut de Barcelona
- Status
- Active, not recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-Chest pain suggestive of myocardial ischemia for at least 30 minutes
- •\-Symptoms onset less than 12 hours before hospital admission
- •\-ST segment elevation of at least 1 mm in two or more contiguous leads (\>o \= 2mm in precordial leads)
- •\-To understand and accept the study procedures and signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 100
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 70
Exclusion Criteria
- •\-ST elevation myocardial infarction presenting with cardiogenic shock
- •\-Previous myocardial infarction (\< 6 months)
- •\-Formal contraindication to thrombolysis or to prasugrel
- •\-Patients on oral anticoagulation therapy
- •\-Patients treated with vitamin K, bivalirudin or fondaparinux
- •\-Patients with severe renal failure (glomerular filtration rate \<30ml/min/m2\)
- •\-Patients with contraindication to study medications, which cannot be managed medically, including: adenosine, heparin, IIb\-IIIa inhibitors, contrast agents, clopidogrel, ticagrelor, prasugrel or aspirin
- •\-Known life\-threatening disease with a life expectancy of \<12 months
- •\-Inability to obtain informed consent
- •\-Patients with contraindications to cardiovascular magnetic resonance
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Revascularisation Delay in Heart Attack StudyHealth Condition 1: I213- ST elevation (STEMI) myocardial infarction of unspecified siteCTRI/2022/02/040002Madras Medical College
Active, not recruiting
Phase 1
Prevention of the reperfusion myocardical damage in patients with acute myocardial infarct submitted to primary PCI through infusion of 'glutatione sale sodico' ev.acute myocardial infarctTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2014-004486-25-ITniversity Hospital Policlinico Umberto I90
Active, not recruiting
Phase 1
yreprofylakse ved ST-segment elevation myokardie infarkt og primær PCIDecreased renal function in patients with STEMI undergoing acute PCIEUCTR2009-017642-32-DKOdense University Hospital
Active, not recruiting
Phase 1
STREAM - STrategic Reperfusion Early After Myocardial InfarctionComparison of the efficacy and safety of a strategy of pre-hospital fibrinolytic treatment with tenecteplase and additional antiplatelet and antithrombin therapy followed by catheterisation within 6-24 hours or rescue coronary intervention versus a strategy of standard primary PCI in patients with acute myocardial infarction within 3 hours of onset of symptoms - STREAMST-elevation myocardial infaction within 3 hours of onset of symptomsMedDRA version: 9.1Level: LLTClassification code 10064345Term: ST segment elevation myocardial infarctionEUCTR2007-001219-44-BESCS Boehringer Ingelheim Comm.V2,000
Active, not recruiting
Phase 1
STREAM - STrategic Reperfusion Early After Myocardial InfarctionComparison of the efficacy and safety of a strategy of pre-hospital fibrinolytic treatment with tenecteplase and additional antiplatelet and antithrombin therapy followed by catheterisation within 6-24 hours or rescue coronary intervention versus a strategy of standard primary PCI in patients with acute myocardial infarction within 3 hours of onset of symptoms - STREAMST-elevation myocardial infaction within 3 hours of onset of symptomsMedDRA version: 9.1Level: LLTClassification code 10064345Term: ST segment elevation myocardial infarctionEUCTR2007-001219-44-FRBoehringer Ingelheim France2,000